期刊文献+

膀胱移行细胞癌中PTEN和p53基因的表达及临床意义 被引量:1

Expression and Significance of PTEN and P53 Gene in Bladder Transitional Cell Cancer
下载PDF
导出
摘要 【目的】研究第10号染色体丢失的张力蛋白同源的磷酸酶基因(PTEN)及p53在膀胱移行上皮细胞癌(BTCC)组织中的表达水平及其与BTCC生物学行为的关系及临床意义。【方法】以免疫组化SP法检测10例正常膀胱黏膜及69例BTCC组织中的PTEN及p53基因的表达水平。【结果】在10例正常膀胱组织中PTEN基因均表达阳性或强阳性,p53基因有1例弱阳性表达,其余9例表达阴性。在69例BTCC组织中PTEN高表达组为46例(66.7%),其中阳性15例,强阳性31例,p53阳性高表达组为39例(56.5%),其中阳性22例,强阳性17例。随着肿瘤分期、分级的增加PTEN表达显著减少(P<0.01);而p53的表达显著增强(P<0.01);PTEN的表达随肿瘤分期、分级而减少与p53的表达增强呈显著负相关(P<0.01)。【结论】PTEN与p53可能成为估计BTCC恶性程度及肿瘤侵袭性的一项有用的指标,p53基因与PTEN基因的表达可能起互相调节作用。 [Objective]To investigate the protein expression of the tumor suppressor gene PTEN(phosphatase and tensin homology deleted on chromosome ten) and P53 gene and their possible roles in the development and progression of bladder transitional cell carcinoma (BTCC). [Methods] Immunohistochemical method was used in detecting PTEN and P53 in 69 BTCC and 10 normal bladder tissues. [Results] The expression of PTEN was positive or strong positive in 10 normal bladder tissues. The expression of P53 gene was weakly positve in one normal bladder tissue and nagative in 9. Forty-six BTCC tissues were high expression of PTEN, 15 positve and 31 strong positive. Thirty-nine BTCC tissues were high expression of P53, 22 positive and 17 strong positive. The positive expression rate of PTEN and P53 gene in BTCC were 66. 7% and 56.5%respectively. The expression of PTEN significantly decreased and the expression of P53 increased with the increment of pathological grades( P〈0. 001). There was significantly inverse correlation between PTEN and P53 expression( P 〈0. 0001). [Conclusion] The abnormal expressions of PTEN and P53 gene rnay play an important role in the malignant progression of BTCC . The expression of PTEN and P53 gene may be regulated by each other.
出处 《医学临床研究》 CAS 2008年第5期831-833,836,共4页 Journal of Clinical Research
关键词 移行细胞/代谢 膀胱肿瘤/代谢 肿瘤抑制蛋白质类/代谢 蛋白质p53/生物合成 carcinoma,transitional cell/ME bladder neoplasms/ME protein p53/BI
  • 相关文献

参考文献11

  • 1Waite KA, Eng C. Protean PTEN: form and funetion[J]. Am J Hum Genet ,2002 ,70(4) :829-44.
  • 2Mayo LD. The PTEN, Mdm2, p53 tumor suppressor- oncoprotein network[J]. Trends Biochem Sci , 2002, 27 (9) : 462- 471.
  • 3Stiles,B. Essential role of AKT-1/protein kinase B alpha in PTEN- controled tumorigenesis[J]. Mol Cell Biol ,2002,22, 3842-3851.
  • 4Gu J, Tamura M,Yamada KM. Tumor suppressor PTEN inhibits integrin -and growth fac-tor - mediated mitogen-actirated protein (MAP) kinase signaling pathway [J]. J Cell Biol , 1998,143 : 1375-1383.
  • 5Steck PA,Perhouse MA, Jasser SA, et al . Idenfication of a candidate tumor supressor gene , MMACI, at chromsome 10q23.3 that is muted in advanced cancer[J]. Nature Genet ,1997,15:356-362.
  • 6Mairin E ,McMenamin ,Peggy Soung , et al . Loss of PTEN expression in paraffin -embedded prinary prostate cancer correlates with high Gleason score and advanced stage[J]. Cancer Res ,1999,59:4291-4296.
  • 7Porter PL,Gown AM,Kranp SG,et al. Widespread p53 overexpression in human malignant tumors[J]. Am J Pothol , 1992,140:145-152.
  • 8Culotta E, Koshland DE. p53 sweeps through cancer reseach [J]. Science , 1993,262:1985.
  • 9Gottieh TM. Cross -talk between Akt , p53 and mdm 2 : possible implication for the regulation of apoptosis[J]. Oncogene , 2002,21:1299-1303.
  • 10Hwang PH, Kim SY, Lee JC, et al . PTEN/MMAC1 en hances the growth inhibition by anticancer drugs with down regulation of IGF-Ⅱ expression in gastric cancer cells[J]. Exp Mol Med ,2005,37(5) :391-398.

同被引文献12

  • 1Higuchi T, Shimizu M, Owaki A, et al. A possible mechanism of intravesical BCG therapy for human bladder carcinoma: involve- ment of innate effector cells for the inhibition of tumor growth. Cancer Immunol Immunother,2009,58 ( 8 ) : 1245-1255.
  • 2Molinero LL, Fuertes MB, Girart MV,et al. NF-Kappa B regulates expression of the MHC class I-related chain A gene in activated T lymphocytes. J Immunol,2004,173 (9) : 5583-5590.
  • 3Lin D, Lavender H, Soilleux EJ, et al. NF-KB regulates MICA gene transcription in endothelial cell through a genetically inhibit- able control site. J Biol Chem,2012,287(6) : 4299-4310.
  • 4Maccalli C, Scaramuzza S, Parmiani G. TNK cells (NKG2D + CD8 + or CD4 + T lymphocytes) in the control of human tumors. Cancer Immunol Immunother 12009,58 ( 5 ) : 801-808.
  • 5Xu X, Rao GS, Groh V, et al. Major histocompatibility complex class I-related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer: role of uric acid accumulation in gemcitabine-induced MICA/B expression. BMC Cancer,2011, 11 (1) :194.
  • 6Kontos S, Sotiropoulou-Bonikou G, Kominea A, et al. Coordinated Increased Expression of Cyclooxygenase2 and Nuclear Factor KB Is a Steady Feature of Urinary Bladder Carcinogenesis. Adv Urol, 2010, pii: 871356.
  • 7Liu G, Atteridge CL, Wang X,et al. The membrane type matrix metalloproteinase MMP14 mediates constitutive shedding of MHC class I chain-related molecule A independent of A disintegrin and metalloproteinases. J Immunol,2010,184 (7) : 3346-3350.
  • 8Robert I, Aussems M, Keutgens A, et al. Matrix Metalloprotein- ase-9 gene induction by a truncated oncogenic NF-kappaB2 pro- tein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes. Oncogene, 2009,28 ( 13 ) : 1626- 1638.
  • 9Textor S, Fiegler N, Arnold A, et al. Human NK cells are alerted to induction of p53 in cancer ceils by upregulation of the NKG2D ligands ULBP1 and ULBP2. Cancer Res, 2011,71 ( 18 ) : 5998- 6009.
  • 10卢善明,薛玲,肖萍,李扬,曹清华,乔慧.骨肉瘤组织中MICA、MMP-9和NF-κB蛋白的表达及相关性[J].临床与实验病理学杂志,2009,25(3):270-273. 被引量:5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部